Giuseppe Remuzzi

Azienda Ospedaliero Universitaria Ospedali Riuniti ORCID: 0000-0002-6194-3446

3

h-index

3

Publications

11,240

Citations

Publications

3 shown

COVID-19 and Italy: what next?

Andrea Remuzzi , Giuseppe Remuzzi

2020 The Lancet 3318 citations

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial

Piero Ruggenenti , Annalisa Perna , Giulia Gherardi +3 more

1998 The Lancet 571 citations

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner , Mark E. Cooper , Dick de Zeeuw +7 more

Losartan conferred significant renal benefits in patients with type 2 diabetes and nephropathy, and it was generally well tolerated.

2001 New England Journal of Medicine 7351 citations

Frequent Co-Authors

Andrea Remuzzi

University of Bergamo

Piero Ruggenenti

Azienda Ospedaliero Universitaria Ospedali Riuniti

Annalisa Perna

Mario Negri Institute for Pharmacological Research

Giulia Gherardi

Mario Negri Institute for Pharmacological Research

Flavio Gaspari

Mario Negri Institute for Pharmacological Research

Roberto Benini

Mario Negri Institute for Pharmacological Research

Researcher Info

h-index: 3
Publications: 3
Citations: 11,240
Institution: Azienda Ospedaliero Universitaria Ospedali Riuniti

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-6194-3446

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.